WP
PRAX icon

Woodline Partners’s Praxis Precision Medicines PRAX Stock Holding History

Woodline Partners’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$64.4M Buy
200,013
+94,601
+90% +$29.3M 0.24% 97
2025
Q4 		$31.1M Sell
105,412
-312,257
-75% -$58.1M 0.12% 221
2025
Q3 		$22.1M Buy
417,669
+371,717
+809% +$18M 0.1% 259
2025
Q2 		$1.93M Sell
45,952
-129,775
-74% -$4.94M 0.01% 727
2025
Q1 		$6.65M Buy
175,727
+165,779
+1,666% +$10.4M 0.04% 436
2024
Q4 		$766K Buy
+9,948
New +$720K 0.01% 794
2024
Q2 		– Sell
-27,263
Closed -$1.66M – 649
2024
Q1 		$1.66M Buy
+27,263
New +$1.22M 0.02% 436
2022
Q3 		– Sell
-20,583
Closed -$756K – 808
2022
Q2 		$756K Hold
20,583
– – 0.01% 538
2022
Q1 		$3.15M Hold
20,583
– – 0.05% 304
2021
Q4 		$6.08M Hold
20,583
– – 0.09% 261
2021
Q3 		$5.71M Sell
20,583
-3,180
-13% -$863K 0.09% 238
2021
Q2 		$6.52M Buy
23,763
+6,985
+42% +$2.5M 0.12% 192
2021
Q1 		$8.24M Sell
16,778
-3,358
-17% -$2.39M 0.18% 141
2020
Q4 		$16.6M Buy
+20,136
New +$11.8M 0.44% 71

Other funds holding PRAX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Woodline Partners's PRAX Position: Q1 2026 in Review

Woodline Partners increased its Praxis Precision Medicines (PRAX) stake by 90% in Q1 2026, buying an estimated $29.3M and bringing the position to 200,013 shares worth $64.4M. The position accounts for 0.24% of the portfolio, ranked #97.

Woodline Partners first reported a position in PRAX in Q4 2020 and has held it in 14 quarters since. 289 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

  • Woodline Partners held 200,013 shares of Praxis Precision Medicines worth $64.4M as of Q1 2026.
  • Woodline Partners bought 94,601 Praxis Precision Medicines shares in Q1 2026, an estimated $29.3M.
  • Praxis Precision Medicines made up 0.24% of Woodline Partners's portfolio in Q1 2026, its #97 holding.
  • Woodline Partners first reported a position in Praxis Precision Medicines in Q4 2020 and has held it in 14 quarters since.
  • 289 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on Woodline Partners's 13F filing for Q1 2026, filed 15 May 2026.